“Additionally, milnacipran (10, 20 and 40 mg/kg) significantly augmented ( p ≤ 0.05) TAC status following carrageenan in the hind paw tissue.”
“Also, milnacipran (20 and 40 mg/kg) significantly suppressed levels of malondialdehyde (MDA), NO ( p ≤ 0.05), MPO activity, TNF-α, IL-1β and IL-6 ( p ≤ 0.001) following carrageenan injection.”